BACK TO ALL STUDIES
Fort Bragg, NC: Post-deployment Paratrooper Point Prevalence Antibody study
PRIMARY OBJECTIVE(s)
To determine the exposure of Soldiers during deployment to SARS-CoV-2 via antibodies to SARS-CoV-2.
PRINCIPAL INVESTIGATOR(S)
Sammy Choi
TREATMENT/CLINICAL & LAB INVESTIGATION
No treatment. SARS-CoV-2 antibody testing.
POPULATION
Fort Bragg active duty Soldiers who have recently returned from deployment
FULL NAME OF DIAGNOSTIC TEST
Lab Used for Diagnostic Test
Full Name of Serology/Antibody Test
SARS-CoV-2 IgG assay on the ARCHTEXT i2000 system.
Lab Used for Serology/Antibody Test
IgG through LabCorp
Want more information about this study?
study website
